Liquid Biopsy in Japan: From Global Vision to Local Reality​

Join this session, where key voices behind key industry collaborations in the liquid biopsy field will come together to share what it truly takes to translate a global vision into local, patient-level impact. In this session you will:​ Delve into the vision that brought SOPHiA GENETICS and MSK together to bring a best-in- class liquid biopsy assay from one lab to the world, to guarantee equal care across borders.​ Understand the evolving landscape of NGS-based liquid biopsy adoption and the remaining barriers to equitable access globally.​ Discover how the strategic partnership between SOPHiA GENETICS and A.D.A.M. Innovations is navigating Japan’s regulatory and infrastructural complexities to unlock the full potential of liquid biopsy for patients across the country.​ Learn how local partnerships are essential to scaling precision oncology globally, streamlining regulatory pathways, and broadening patient access across diverse healthcare settings.​